Skip to content

Nasdaq · CIK 0001636422

HCAT Health Catalyst, Inc.

Insider trading from SEC Form 4. Last filing 7 d ago. Close $1.77 on Oct 9, 2026, +78% from the 52-week low and -49% from the high.

Last 90 days

Net insider value
+$105k
more bought than sold
Buys
1
$105k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
16
with a Form 4 at this company

Price and insider trades, last year

HCATOct 9, 2026 · close 1.77

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Health Catalyst, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
43ModerateSimeon Kohl
Chief Executive Officer
buy
$105k
59,000 shares
+2%+83% from low-47% from high
44ModerateJulie Larson-Green
director
sell
$128k
47,997 shares
-39%+33% from low-68% from high
16WeakBenjamin Landry
General Counsel
sell
$72k
27,425 shares
-22%+28% from low-69% from high
0WeakBenjamin Landry
General Counsel
sell
$21k
6,175 shares
-4%+25% from low-63% from high
0WeakBenjamin Landry
General Counsel
sell
$24k
6,057 shares
-4%+7% from low-57% from high
0WeakDaniel LeSueur
Chief Operating Officer
sell
$21k
5,209 shares
-2%+14% from low-55% from high
0WeakDaniel LeSueur
Chief Operating Officer
sell
$22k
5,209 shares
-2%+4% from low-54% from high
16WeakDaniel LeSueur
Chief Operating Officer
sell
$76k
16,902 shares
-7%+4% from low-50% from high
11WeakBenjamin Landry
General Counsel
sell
$63k
13,827 shares
-8%+1% from low-51% from high
9WeakLinda Llewelyn
Chief People Officer
sell
$35k
6,441 shares
-7%0% from low-40% from high
13WeakDaniel LeSueur
Chief Operating Officer
sell
$30k
5,209 shares
-6%+8% from low-35% from high
16WeakLinda Llewelyn
Chief People Officer
sell
$37k
6,442 shares
-7%0% from low-36% from high
10WeakBenjamin Landry
General Counsel
sell
$19k
2,500 shares
-3%+7% from low-18% from high
21WeakDaniel LeSueur
Chief Operating Officer
sell
$39k
5,209 shares
-5%+7% from low-18% from high
15WeakDuncan Gallagher
director
sell
$31k
4,500 shares
-6%+2% from low-22% from high
15WeakDuncan Gallagher
director
sell
$31k
4,500 shares
-6%0% from low-23% from high
17WeakLinda Llewelyn
Chief People Officer
sell
$51k
6,442 shares
-6%+7% from low-13% from high
33WeakJason Alger
Chief Financial Officer
sell
$163k
19,599 shares
-18%-
26WeakBenjamin Landry
General Counsel
sell
$160k
19,268 shares
-21%-
32WeakDaniel LeSueur
Chief Operating Officer
sell
$175k
22,773 shares
-19%-
18WeakKevin Lee Freeman
Chief Commercial Officer
sell
$67k
7,500 shares
-3%-
3WeakLinda Llewelyn
Chief People Officer
sell
$12k
1,365 shares
-1%-
14WeakDaniel LeSueur
Chief Operating Officer
sell
$40k
5,209 shares
-4%-
0WeakLinda Llewelyn
Chief People Officer
sell
$11k
1,324 shares
-1%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Mar 6, 2025 BENJAMIN LANDRY
Officer
13,827
0.02% of outstanding
$63kMar 6, 2025$60k
Mar 5, 2025 DANIEL LESUEUR
Officer
16,902
0.02% of outstanding
$76kMar 5, 2025$111k
Mar 3, 2025 Jason Alger
Officer
7,304
0.01% of outstanding
$33kMar 3, 2025$233k
Mar 3, 2025 Daniel Burton
Officer
33,677
0.05% of outstanding
$154kMar 3, 2025$278k
Mar 3, 2025 Kevin Freeman
Officer
10,800
0.02% of outstanding
$49kMar 3, 2025$170k
Mar 3, 2025 Daniel LeSueur
Officer
9,232
0.01% of outstanding
$42kMar 3, 2025$338k
Mar 3, 2025 Benjamin Landry
Officer
9,024
0.01% of outstanding
$41kMar 3, 2025$264k
Mar 3, 2025 Linda Llewelyn
Officer
7,525
0.01% of outstanding
$34kMar 3, 2025$193k
Feb 18, 2025 LINDA LLEWELYN
Officer
6,641
0.01% of outstanding
$36kFeb 18, 2025$158k
Feb 5, 2025 DANIEL LESUEUR
Officer
5,209
0.01% of outstanding
$29kFeb 5, 2025$308k
Jan 15, 2025 LINDA LLEWELYN
Officer
6,442
0.01% of outstanding
$38kJan 15, 2025$132k
Jan 6, 2025 DANIEL LESUEUR
Officer
5,209
0.01% of outstanding
$39kJan 6, 2025$309k
Jan 6, 2025 BENJAMIN LANDRY
Officer
2,500
0.00% of outstanding
$19kJan 6, 2025$245k
Dec 30, 2024 DUNCAN GALLAGHER
Director
4,500
0.01% of outstanding
$32kDec 30, 2024$31k
Dec 23, 2024 DUNCAN GALLAGHER
Director
4,500
0.01% of outstanding
$32kDec 23, 2024none
Dec 16, 2024 LINDA LLEWELYN
Officer
6,442
0.01% of outstanding
$51kDec 16, 2024$92k
Dec 6, 2024 JASON ALGER
Officer
19,599
0.03% of outstanding
$162kDec 6, 2024$70k
Dec 6, 2024 BENJAMIN LANDRY
Officer
19,268
0.03% of outstanding
$159kDec 6, 2024$85k
Dec 4, 2024 DANIEL LESUEUR
Officer
22,773
0.04% of outstanding
$181kDec 4, 2024$174k
Dec 2, 2024 Jason Alger
Officer
7,795
0.01% of outstanding
$70kDec 2, 2024$30k
Dec 2, 2024 Daniel Burton
Officer
30,987
0.05% of outstanding
$278kDec 2, 2024$30k
Dec 2, 2024 Kevin Freeman
Officer
11,431
0.02% of outstanding
$103kDec 2, 2024$74k
Dec 2, 2024 KEVIN FREEMAN
Officer
7,500
0.01% of outstanding
$66kDec 2, 2024$54k
Dec 2, 2024 Daniel LeSueur
Officer
10,455
0.02% of outstanding
$94kDec 2, 2024$155k
Dec 2, 2024 Benjamin Landry Officer
Officer
9,419
0.02% of outstanding
$84kDec 2, 2024$27k

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026Tami Reller
director
AGrant or award
Common Stock
+128,851$0.00$0128,8517 d ago
Sep 14, 2026Simeon Kohl
Chief Executive Officer
AGrant or award
Common Stock
+2,747,385$0.00$02,797,38526 d ago
Sep 14, 2026Simeon Kohl
Chief Executive Officer
POpen-market purchase
Common Stock
+59,000$1.79$105k2,856,38526 d ago
Sep 10, 2026Benjamin Albert
CEO
FTax withholding
Common Stock
-35,244$1.67$59k1,388,40631 d ago
Sep 1, 2026Benjamin Landry
General Counsel
FTax withholding
Common Stock
-13,167$1.70$22k351,37239 d ago
Sep 1, 2026Julie Larson-Green
director
AGrant or award
Common Stock
+9,766$0.00$0185,10139 d ago
Sep 1, 2026Benjamin Albert
CEO
FTax withholding
Common Stock
-321$1.70$5471,423,65039 d ago
Sep 1, 2026Jason Alger
Chief Financial Officer
FTax withholding
Common Stock
-17,973$1.70$31k704,86739 d ago
Jun 10, 2026Benjamin Albert
CEO
FTax withholding
Common Stock
-34,485$1.69$58k1,423,971Jun 15, 2026
Jun 1, 2026Benjamin Albert
CEO
FTax withholding
Common Stock
-336$1.37$4601,458,456Jun 3, 2026
Jun 1, 2026Jason Alger
Chief Financial Officer
FTax withholding
Common Stock
-18,804$1.37$26k722,840Jun 3, 2026
Apr 29, 2026Benjamin Albert
CEO
AGrant or award
Common Stock
+1,124$0.00$01,459,102May 1, 2026
May 1, 2026Benjamin Albert
CEO
FTax withholding
Common Stock
-310$1.35$4171,458,792May 1, 2026
Mar 10, 2026Benjamin Albert
CEO
FTax withholding
Common Stock
-70,455$1.85$130k1,457,978Mar 13, 2026
Mar 2, 2026Linda Llewelyn
Chief People Officer
FTax withholding
Common Stock
-13,836$1.66$23k329,651Mar 5, 2026
Mar 2, 2026Benjamin Landry
General Counsel
FTax withholding
Common Stock
-20,838$1.66$35k378,318Mar 5, 2026
Mar 1, 2026Julie Larson-Green
director
AGrant or award
Common Stock
+8,361$0.00$081,934Mar 5, 2026
Mar 2, 2026Jason Alger
Chief Financial Officer
FTax withholding
Common Stock
-26,970$1.66$45k741,644Mar 5, 2026
Mar 2, 2026Benjamin Albert
CEO
FTax withholding
Common Stock
-4,966$1.66$8,2431,528,433Mar 5, 2026
Feb 25, 2026Benjamin Albert
CEO
AGrant or award
Common Stock
+930,000$0.00$01,507,870Feb 27, 2026
Feb 25, 2026Jason Alger
Chief Financial Officer
AGrant or award
Common Stock
+507,500$0.00$0753,914Feb 27, 2026
Feb 25, 2026Linda Llewelyn
Chief People Officer
AGrant or award
Common Stock
+191,500$0.00$0334,763Feb 27, 2026
Feb 25, 2026Benjamin Landry
General Counsel
AGrant or award
Common Stock
+289,000$0.00$0389,000Feb 27, 2026
Feb 25, 2026Benjamin Albert
CEO
AGrant or award
Common Stock
+38,833$0.00$01,546,703Feb 27, 2026
Feb 25, 2026Jason Alger
Chief Financial Officer
AGrant or award
Common Stock
+22,222$0.00$0776,136Feb 27, 2026
Feb 25, 2026Linda Llewelyn
Chief People Officer
AGrant or award
Common Stock
+13,195$0.00$0347,958Feb 27, 2026
Feb 25, 2026Benjamin Landry
General Counsel
AGrant or award
Common Stock
+16,473$0.00$0405,473Feb 27, 2026
Feb 26, 2026Linda Llewelyn
Chief People Officer
FTax withholding
Common Stock
-4,471$1.75$7,814343,487Feb 27, 2026
Feb 26, 2026Jason Alger
Chief Financial Officer
FTax withholding
Common Stock
-7,522$1.75$13k768,614Feb 27, 2026
Feb 26, 2026Benjamin Albert
CEO
FTax withholding
Common Stock
-13,304$1.75$23k1,533,399Feb 27, 2026
Feb 26, 2026Benjamin Landry
General Counsel
FTax withholding
Common Stock
-6,317$1.75$11k399,156Feb 27, 2026
Feb 17, 2026Duncan Gallagher
director
AGrant or award
Common Stock
+7,562$0.00$0132,023Feb 19, 2026
Dec 5, 2025Benjamin Landry
General Counsel
SOpen-market sale
Common Stock10b5-1
-27,425$2.64$72k100,000Dec 9, 2025
Dec 4, 2025Julie Larson-Green
director
SOpen-market sale
Common Stock
-47,997$2.67$128k73,573Dec 9, 2025
Dec 1, 2025Jason Alger
Chief Financial Officer
FTax withholding
Common Stock
-20,619$2.90$60k246,414Dec 3, 2025
Dec 1, 2025Daniel D. Burton
Chief Executive Officer
FTax withholding
Common Stock
-55,715$2.90$162k1,393,099Dec 3, 2025
Dec 1, 2025Kevin Lee Freeman
Chief Commercial Officer
FTax withholding
Common Stock
-16,401$2.90$48k358,686Dec 3, 2025
Dec 1, 2025Duncan Gallagher
director
AGrant or award
Common Stock
+6,209$0.00$0124,461Dec 3, 2025
Dec 1, 2025Linda Llewelyn
Chief People Officer
FTax withholding
Common Stock
-9,762$2.90$28k143,263Dec 3, 2025
Dec 1, 2025Julie Larson-Green
director
AGrant or award
Common Stock
+5,731$0.00$0121,570Dec 3, 2025
Dec 1, 2025Benjamin Landry
General Counsel
FTax withholding
Common Stock
-14,387$2.90$42k127,425Dec 3, 2025
Sep 24, 2025Benjamin Albert
President and COO
AGrant or award
Common Stock
+467,000$0.00$0577,870Sep 26, 2025
Sep 5, 2025Benjamin Landry
General Counsel
SOpen-market sale
Common Stock10b5-1
-6,175$3.35$21k141,812Sep 9, 2025
Sep 1, 2025Duncan Gallagher
director
AGrant or award
Common Stock
+4,970$0.00$0118,252Sep 5, 2025
Sep 1, 2025Julie Larson-Green
director
AGrant or award
Common Stock
+4,588$0.00$0115,839Sep 5, 2025
Sep 2, 2025Jason Alger
Chief Financial Officer
FTax withholding
Common Stock
-2,613$3.36$8,787267,033Sep 4, 2025
Sep 2, 2025Daniel D. Burton
Chief Executive Officer
FTax withholding
Common Stock
-8,335$3.36$28k1,448,814Sep 4, 2025
Sep 2, 2025Kevin Lee Freeman
Chief Commercial Officer
FTax withholding
Common Stock
-4,578$3.36$15k375,087Sep 4, 2025
Sep 2, 2025Benjamin Landry
General Counsel
FTax withholding
Common Stock
-3,138$3.36$11k147,987Sep 4, 2025
Sep 2, 2025Linda Llewelyn
Chief People Officer
FTax withholding
Common Stock
-2,854$3.36$9,597153,025Sep 4, 2025
Sep 2, 2025Daniel LeSueur
Chief Operating Officer
FTax withholding
Common Stock
-3,663$3.36$12k198,367Sep 4, 2025
Sep 2, 2025David Coy Ross
Chief Tech & Product Officer
FTax withholding
Common Stock
-3,360$3.36$11k204,219Sep 4, 2025
Sep 1, 2025Justin Spencer
director
AGrant or award
Common Stock
+68,572$0.00$068,572Sep 3, 2025
Jul 9, 2025S. Dawn Smith
director
AGrant or award
Common Stock
+36,231$0.00$0101,692Jul 11, 2025
Jul 9, 2025Duncan Gallagher
director
AGrant or award
Common Stock
+36,231$0.00$0113,282Jul 10, 2025
Jul 9, 2025Julie Larson-Green
director
AGrant or award
Common Stock
+36,231$0.00$0111,251Jul 10, 2025
Jul 9, 2025John A Kane
director
AGrant or award
Common Stock
+36,231$0.00$0170,719Jul 10, 2025
Jul 9, 2025Green Jill Hoggard
director
AGrant or award
Common Stock
+36,231$0.00$063,937Jul 10, 2025
Jun 5, 2025Benjamin Landry
General Counsel
SOpen-market sale
Common Stock10b5-1
-6,057$3.94$24k151,125Jun 9, 2025
Jun 2, 2025Daniel LeSueur
Chief Operating Officer
FTax withholding
Common Stock
-3,802$3.63$14k202,030Jun 3, 2025
Jun 2, 2025Benjamin Landry
General Counsel
FTax withholding
Common Stock
-3,255$3.63$12k157,182Jun 3, 2025
Jun 1, 2025Duncan Gallagher
director
AGrant or award
Common Stock
+4,080$0.00$077,051Jun 3, 2025
Jun 1, 2025Julie Larson-Green
director
AGrant or award
Common Stock
+3,766$0.00$075,020Jun 3, 2025
Jun 2, 2025Jason Alger
Chief Financial Officer
FTax withholding
Common Stock
-2,712$3.63$9,858269,646Jun 3, 2025
Jun 2, 2025Daniel D. Burton
Chief Executive Officer
FTax withholding
Common Stock
-8,658$3.63$31k1,457,149Jun 3, 2025
Jun 2, 2025Kevin Lee Freeman
Chief Commercial Officer
FTax withholding
Common Stock
-4,747$3.63$17k379,665Jun 3, 2025
Jun 2, 2025Linda Llewelyn
Chief People Officer
FTax withholding
Common Stock
-2,965$3.63$11k155,879Jun 3, 2025
May 5, 2025Daniel LeSueur
Chief Operating Officer
SOpen-market sale
Common Stock10b5-1
-5,209$4.10$21k205,832May 7, 2025
Apr 3, 2025Daniel LeSueur
Chief Operating Officer
SOpen-market sale
Common Stock10b5-1
-5,209$4.15$22k211,041Apr 7, 2025
Mar 6, 2025Benjamin Landry
General Counsel
SOpen-market sale
Common Stock10b5-1
-13,827$4.55$63k160,437Mar 10, 2025
Mar 5, 2025Daniel LeSueur
Chief Operating Officer
SOpen-market sale
Common Stock10b5-1
-16,902$4.52$76k216,250Mar 10, 2025
Mar 3, 2025Jason Alger
Chief Financial Officer
FTax withholding
Common Stock
-7,304$4.58$33k272,358Mar 4, 2025
Mar 3, 2025Daniel D. Burton
Chief Executive Officer
FTax withholding
Common Stock
-33,677$4.58$154k1,465,807Mar 4, 2025
Mar 3, 2025Kevin Lee Freeman
Chief Commercial Officer
FTax withholding
Common Stock
-10,800$4.58$49k384,412Mar 4, 2025
Mar 3, 2025Linda Llewelyn
Chief People Officer
FTax withholding
Common Stock
-7,525$4.58$34k158,844Mar 4, 2025
Mar 3, 2025Benjamin Landry
General Counsel
FTax withholding
Common Stock
-9,024$4.58$41k174,264Mar 4, 2025
Mar 3, 2025Daniel LeSueur
Chief Operating Officer
FTax withholding
Common Stock
-9,232$4.58$42k233,152Mar 4, 2025
Mar 1, 2025Duncan Gallagher
director
AGrant or award
Common Stock
+3,033$0.00$072,971Mar 4, 2025
Mar 1, 2025Julie Larson-Green
director
AGrant or award
Common Stock
+2,450$0.00$071,254Mar 4, 2025
Feb 20, 2025Jason Alger
Chief Financial Officer
AGrant or award
Common Stock
+181,000$0.00$0267,712Feb 24, 2025
Feb 20, 2025Daniel D. Burton
Chief Executive Officer
AGrant or award
Common Stock
+296,000$0.00$01,424,047Feb 24, 2025
Feb 20, 2025Kevin Lee Freeman
Chief Commercial Officer
AGrant or award
Common Stock
+140,000$0.00$0376,950Feb 24, 2025
Feb 20, 2025Daniel LeSueur
Chief Operating Officer
AGrant or award
Common Stock
+145,000$0.00$0231,044Feb 24, 2025
Feb 20, 2025Linda Llewelyn
Chief People Officer
AGrant or award
Common Stock
+69,000$0.00$0154,819Feb 24, 2025
Feb 20, 2025Benjamin Landry
General Counsel
AGrant or award
Common Stock
+97,500$0.00$0169,750Feb 24, 2025
Feb 20, 2025Jason Alger
Chief Financial Officer
AGrant or award
Common Stock
+11,950$0.00$0279,662Feb 24, 2025
Feb 20, 2025Daniel D. Burton
Chief Executive Officer
AGrant or award
Common Stock
+75,437$0.00$01,499,484Feb 24, 2025
Feb 20, 2025Kevin Lee Freeman
Chief Commercial Officer
AGrant or award
Common Stock
+18,262$0.00$0395,212Feb 24, 2025
Feb 20, 2025Daniel LeSueur
Chief Operating Officer
AGrant or award
Common Stock
+11,340$0.00$0242,384Feb 24, 2025
Feb 20, 2025Linda Llewelyn
Chief People Officer
AGrant or award
Common Stock
+11,750$0.00$0166,369Feb 24, 2025
Feb 20, 2025Benjamin Landry
General Counsel
AGrant or award
Common Stock
+13,538$0.00$0183,288Feb 24, 2025
Feb 18, 2025Linda Llewelyn
Chief People Officer
SOpen-market sale
Common Stock10b5-1
-6,441$5.43$35k85,819Feb 20, 2025
Feb 5, 2025Daniel LeSueur
Chief Operating Officer
SOpen-market sale
Common Stock10b5-1
-5,209$5.76$30k86,044Feb 6, 2025
Jan 15, 2025Linda Llewelyn
Chief People Officer
SOpen-market sale
Common Stock10b5-1
-6,442$5.80$37k92,260Jan 17, 2025
Jan 6, 2025Benjamin Landry
General Counsel
SOpen-market sale
Common Stock10b5-1
-2,500$7.52$19k72,250Jan 10, 2025
Jan 6, 2025Daniel LeSueur
Chief Operating Officer
SOpen-market sale
Common Stock10b5-1
-5,209$7.51$39k91,253Jan 10, 2025
Dec 30, 2024Duncan Gallagher
director
SOpen-market sale
Common Stock10b5-1
-4,500$6.93$31k69,938Jan 2, 2025
Dec 23, 2024Duncan Gallagher
director
SOpen-market sale
Common Stock10b5-1
-4,500$6.98$31k74,438Dec 27, 2024
Dec 16, 2024Linda Llewelyn
Chief People Officer
SOpen-market sale
Common Stock10b5-1
-6,442$7.88$51k98,702Dec 18, 2024
Dec 6, 2024Jason Alger
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-19,599$8.32$163k86,712Dec 10, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

HCAT insider trading: Health Catalyst, Inc. | InsiderTell